RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 91 filers reported holding RHYTHM PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $41,000 | -100.0% | 10 | -99.9% | 0.00% | -100.0% |
| Q1 2022 | $117,877,000 | +49.8% | 10,233 | +29.8% | 0.03% | +73.7% |
| Q4 2021 | $78,699,000 | -21.4% | 7,886 | +52.6% | 0.02% | -17.4% |
| Q2 2021 | $100,134,000 | -8.9% | 5,167 | 0.0% | 0.02% | -25.8% |
| Q1 2021 | $109,897,000 | -40.1% | 5,167 | -16.3% | 0.03% | -42.6% |
| Q4 2020 | $183,545,000 | +37.2% | 6,174 | 0.0% | 0.05% | +38.5% |
| Q3 2020 | $133,783,000 | +0.7% | 6,174 | +3.6% | 0.04% | +8.3% |
| Q2 2020 | $132,899,000 | +46.5% | 5,960 | 0.0% | 0.04% | +44.0% |
| Q1 2020 | $90,707,000 | – | 5,960 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 909,258 | $11,875,000 | 2.75% |
| RA Capital Management | 4,871,067 | $63,616,000 | 0.88% |
| NEA Management Company, LLC | 4,912,306 | $64,155,000 | 0.76% |
| Samsara BioCapital, LLC | 300,293 | $3,922,000 | 0.62% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,989,625 | $25,985,000 | 0.51% |
| Baker Brothers Advisors | 3,863,239 | $50,454,000 | 0.22% |
| ACT CAPITAL MANAGEMENT, LLC | 31,000 | $405,000 | 0.21% |
| Rock Springs Capital Management LP | 612,180 | $7,995,000 | 0.17% |
| GILDER GAGNON HOWE & CO LLC | 1,496,424 | $19,543,000 | 0.10% |
| FEDERATED HERMES, INC. | 3,011,053 | $39,324,000 | 0.08% |